Cargando…
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
BACKGROUND: Despite the current treatments available for panic disorder (PD), as many as one-third of patients have persistent and treatment-resistant panic attacks. Vortioxetine is an approved medicine for major depressive disorder and has been shown to have anxiolytic properties. The purpose of th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946398/ https://www.ncbi.nlm.nih.gov/pubmed/29760763 http://dx.doi.org/10.1186/s12991-018-0190-6 |